for Candida krusei [13] . This increased incidence can be attributed to improvements in diagnostic methods and the emergence of molecular techniques. However, it can also be a reflection of the high level of resistance often exhibited by NCAC species to antifungal therapies, such as the azole drugs and their derivatives, which continue to dominate as the choice against Candida-related infections [14] [15] [16] [17] . Candidosis can be treated, not only by the azole class, but also by echinocandins and polyenes antifungal classes. The selection of the antifungal agent depends on the local epidemiology, percentage of strains resistant to fluconazole and even origin of infection [18] . In addition, at least 70% of the antifungal drugs are prescribed empirically [19] and, consequently, a decrease in susceptibility to fluconazole, along with cross-resistance to other azoles, have been noted, as, for example, in the case of C. glabrata [20] . Thus, in order to overcome this clinical problem, an enlarged interest in finding new effective natural drugs, such as plant extract compounds (specifically some phenolic compounds) and essential oils, has been observed [21] [22] [23] . In this context, the main objective of the present work was to evaluate the potential antifungal effect of gallic acid, catechin, luteolin and quercetin, phenolic compounds identified in flowers of the North Eastern Portugal, against Candida planktonic and biofilm cells (C. albicans American Type Culture Collection [ATCC] 90028, C. tropicalis ATCC 750, C. parapsilosis ATCC 22019 and C. glabrata ATCC 2001).
Materials & methods

•
• Phenolic compounds
The extraction, identification and quantification of phenolic compounds from flowers of Castanea sativa, Filipendula ulmaria, Rosa micrantha [24] and Cytisus multiflorus [25] , and fresh leaves of Cistus ladanifer [26] were previously described by the authors using a high-performance liquid chromatography-diode array detector/electrospray source mass spectrometer. This work was focused on four different phenolic compounds that seemed more promising against Candida species: one phenolic acid (gallic acid) and three flavonoids (catechin, luteolin and quercetin).
•
• Strains & growth conditions
Four Candida reference strains from the ATCC, namely C. albicans (ATCC 90028), C. glabrata (ATCC 2001), C. parapsilosis (ATCC 22019) and C. tropicalis (ATCC 750), were used in this study. Cells were grown on Sabouraud dextrose agar (SDA; Merck, Munich, Germany) for 24 h at 37°C, then inoculated in Sabouraud dextrose broth (Merck) and incubated for 18 h at 37°C under agitation at 120 rpm/min. After incubation, the cells were harvested by centrifugation at 3000 × g for 10 min at 4°C and washed twice in 15 ml of phosphate-buffered saline (PBS; pH 7; 0.1 M). Pellets formed were suspended in 10 ml Roswell Park Memorial Institute (RPMI) 1640 medium (Sigma, MO, USA) buffered to pH 7 and the cellular density was adjusted to 2 × 10 7 cells/ml using a Neubauer chamber.
• Phenolic compound activity against planktonic Candida cells (MIC)
The MICs of all the species under study were determined according to the guidelines of the National Committee for Clinical Laboratory Standards M27-A2 document [27] , with some modifications. Previously to these experiences, twofold final concentration serial dilutions of each compound stock were prepared in RPMI 1640 medium ranging from 0.156 to 1.5 mg/ml and maintained in a freezer. Aliquots of each phenolic compound (100 µl), at a twofold final concentration, and Candida species suspensions (100 µl at 2 × 10 7 cells/ml, fmaor a final concentration of 1 × 10 7 cells/ml) were mixed in the 96-well plates (Orange Scientific, Braine-l' Alleud, Belgium). The 96-well plates were incubated at 37°C for 48 h and then the MIC value was determined, firstly by direct observation and secondly by determination of the number of CFUs. The number of CFUs was determined after appropriate serial dilutions in PBS and by plating 10 µl of each cell dilution onto SDA. After 24h of incubation at 37°C, the number of colonies was enumerated. These experiments were performed three-times and, at least, in triplicate. Yeast cultures without phenolic compounds and negative controls (only RPMI) were also included.
• • Phenolic compounds activity against Candida biofilms Phenolic compounds were tested against Candida species biofilms. For that, standardized Candida cell suspensions (200 µl containing 1 × 10 7 cells/ml in RPMI 1640 medium) were placed into wells of 96-well polystyrene microtiter plates (Orange Scientific) and incubated at 37°C on a shaker at 120 rpm/min for 24 h. The 96-well plates used in this study are often applied to form biofilms, since they possess properties completely different from the plates used for MIC determination assays. In addition, according to our previous results, it was possible to confirm that after 24 h of growth on those plates, there was matrix production, therefore confirming the presence of a biofilm [ At 24 h, biofilm medium was aspirated and nonadherent cells removed by washing the biofilms once in 200 µl of PBS. Then, 200 µl of each phenolic compound (prepared in RPMI 1640 medium), ranging from 0.625 to 5 mg/ml, were added. The biofilms were incubated for a further 24 h at 37°C on a shaker at 120 rpm/min. The effect of phenolic compounds on Candida biofilms was assessed through quantification of the number of CFUs. It is important to emphasize that cells initially used to produce a biofilm are free floating and only some of them form the biofilm. Therefore, the numbers of the initial inoculum and cells within a biofilm cannot be directly correlated. For that, the volume of total medium was removed and the biofilms were washed once with 200 µl of PBS. Then, the biofilms were scraped from the respective wells and the suspensions vigorously vortexed for approximately 2 min to disaggregate cells from the matrix. Serial dilutions were made in PBS, plated onto SDA and incubated for 24 h at 37°C. These experiments were performed in triplicate and, at least, in three independent assays. The results were presented in terms of Log of CFUs.
• Statistical analysis
Results were compared using two-way analysis of variance by applying the Bonferroni post-test for means comparisons, using GraphPad Prism 6 (GraphPad Software, CA, USA).
Results & discussion
In nature, phenolic compounds are involved in plant growth and reproduction, and, curiously, provide resistance to plant pathogens and even predators, protecting crops and seed from diseases [28, 29] . With over 9000 natural antimicrobials identified, the flavonoid family is the largest group of phenolic compounds [30] . It is important to emphasize that the phenolic compounds used in this study, gallic acid (phenolic acid), catechin (flavan-3-ols), luteolin (flavone) and quercetin (flavonol), were previously identified in different medicinal flower species [24] [25] [26] .
The MIC values were determined and ranged from 0.156 to 1.250 mg/ml, as can be observed in Table 1 . In addition, the MIC values were also confirmed measuring Candida planktonic cells (CFU determination) viability (Figure 1) .
The results presented in Table 1 clearly demonstrate that gallic acid was the most effective (<0.156 mg/ml) against the planktonic Candida cells for all the studied species. In addition, catechin demonstrated a similar effect against C. albicans ATCC 90028 cells. It is important to highlight that the catechin, for example, demonstrates a higher effect than the one presented by Haghighi et al. in 2011, which found a MIC value of 9.47 mg/ml against C. albicans [31] , even though the actual mechanism of action of gallic acid on yeast cells has not been widely studied. In 2011, Hong et al. proved that gallic acid present in a hydrolysable tannin extracted from the bark of Rhizophora apiculata possessed anti-C. albicans activity [32] . Although luteolin has been previously reported to exhibit antimicrobial activity against Bacillus cereus and Salmonella enteritidi [33] , and quercetin against Staphylococcus aureus, Escherichia coli and Pseudomonas fluorescens [34] , in this work, these phenolic compounds demonstrated a lower effect against all Candida species cells (≥0.625 mg/ml). The highest resistance of C. tropicalis ATCC 750 cells to all the flavonoids in this study (MIC: Figure 1A-D) . It should be noticed that gallic acid is in fact a causative agent of at least 2 Log of reduction for all species, at the lowest concentration tested (0.156 mg/ml). Interestingly, this phenolic acid also possessed the capability to totally eradicate C. parapsilosis ATCC 22019 ( Figure 1C ) and C. tropicalis ATCC 750 ( Figure 1D ) planktonic cells at concentrations higher than 0.625 (p < 0.001) and 1.25 mg/ml (p < 0.001), respectively. Despite the fact that the mechanism of action of gallic acid on yeast cells has not been widely understood, it can be proposed that it acts by disrupting the structure of the cell membrane and inhibiting the normal budding process [38] [39] [40] . Candida glabrata ATCC 2001 was the species that, in general, presented the highest initial reduction for all Figure 1A ). Catechin and luteolin presented a similar effect against C. parapsilosis ATCC 22019, causing more than 3 Log of reduction at 1.25 mg/ml (p < 0.001) ( Figure 1C) . In this study, C. tropicalis ATCC 750 was the species that showed the lowest inhibition for all flavonoids, with less than 1 Log of reduction, even for the highest concentration tested ( Figure 1D) . So, despite the highest genetic similarity between C. tropicalis ATCC 750 and C. albicans ATCC 90028 [41] , no similarities were found in terms of the phenolic compound effect. In most natural environments, microorganisms exist predominantly as biofilms, rather than planktonic or free-floating cells [42] . Therefore, the second aim of this work was to test the phenolic compounds against Candida species preformed biofilms. For that, the relative numbers of viable cells within the biofilm were evaluated by CFU counts (Figure 2) . Biofilm drug resistance is a phenomenon consistently expressed across model microbial systems [3, 43] and likely to be of great clinical relevance [44] . Hawser and Douglas, in 1995, firstly demonstrated a similar resistance effect of Candida biofilms to traditional antifungal agents [45] . As such, any evidence of activity against biofilm-associated organisms would represent an important new finding.
The effects of the phenolic compounds on Candida biofilms (Figure 2 ) reveled a decreased susceptibility to these microorganisms comparatively with planktonic counterparts (Figure 1) . Gallic acid, the phenolic compound that demonstrated the highest effect for planktonic cells, luteolin and quercetin, was only able to reduce In terms of species, C. albicans ATCC 90028 biofilms were the most resistant to all compounds, where the best results were obtained with gallic acid and quercetin (p < 0.05) (Figure 2A ). In 2009, Wang et al. also showed a great antifungal effect of gallic acid against C. albicans biofilms [46] . Moreover, catechin was the phenolic compound under study, which had demonstrated the lowest effect, with the exception of 1 Log of reduction at the highest concentration, tested in the case of C. parapsilosis ATCC 22019 (p < 0.05) ( Figure 2C ). As it is known, biofilms are organized, structured communities embedded within a matrix of extracellular material [42] . Moreover, Candida biofilm matrix structure and composition is strongly species dependent [42, 46] . For example, C. albicans ATCC 90028 biofilm structure involves, generally, two distinct layers: a thin, basal yeast layer and a thicker, less compact hyphal layer, while C. parapsilosis ATCC 22019 biofilms are thinner and less structured, and consist exclusively of aggregated blastospores [47] , which could justify the difference of results obtained for each Candida species. 
Conclusion
EXECuTiVE SummARY
Objectives of the study • The main aim of this study was to evaluate the antifungal effect of gallic acid, catechin, luteolin and quercetin, a set of phenolic compounds identified from flowers of North Eastern Portugal, against planktonic and biofilm cells of four of the most pathogenic Candida species. 
